ArticleFrontiers in neuroscience2026
Integrating anatomical priors and clinical semantics for MRI-based diagnosis and care support in Alzheimer's disease.
Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder, and magnetic resonance imaging (MRI) has become an important tool for its auxiliary diagnosis because it can reveal key structural abnormalities, including hippocampal and parahippocampal atrophy, ventricular enlargement, temporal cortical degeneration, and gray matter loss. However, reliable stage-aware classification remains challenging because current methods are still limited in handling weak anatomical boundaries, low-contrast lesions, subtle inter-stage differences, and the semantic gap between neuroimaging features and clinical descriptions. To address these issues, we propose AFCG-Net, a diagnosis-guided and frequency-aware cross-modal network for joint MRI-text diagnosis. The framework consists of three stages: anatomy-guided visual encoding, cross-modal semantic alignment, and gated fusion with anatomical priors. Specifically, ASFG enhances visual representations through multi-scale modeling and low frequency-guided refinement, CASF strengthens the consistency between clinical semantics and imaging features, and AGDF performs anatomy-guided deep fusion to improve both discriminability and interpretability. Experiments on a combined cohort of 4,197 original MRI-text samples, including 2,106 self-collected samples and 2,091 ADNI samples, show that AFCG-Net achieves Precision, Recall, and F-score values of 96.3%, 96.5%, and 95.8%, respectively. The proposed method achieves the best results in the Mild dementia and Moderate dementia categories, while also showing stronger performance in the more challenging Non-dementia and Very Mild dementia categories. These results suggest that AFCG-Net provides an effective and interpretable multimodal solution for AD-assisted diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.